Israel Metabolomics Market (2025-2031) | Industry, Size & Revenue, Value, Trends, Share, Outlook, Analysis, Segmentation, Companies, Growth, Forecast, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Metabolomics Market Revenues & Volume, 2021 & 2031F

3.3 Israel Metabolomics Market - Industry Life Cycle

3.4 Israel Metabolomics Market - Porter's Five Forces

3.5 Israel Metabolomics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 Israel Metabolomics Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 Israel Metabolomics Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing investment in research and development activities in the healthcare sector in Israel.

4.2.2 Increasing prevalence of chronic diseases driving the demand for advanced metabolomics technologies.

4.2.3 Government initiatives and funding to support metabolomics research and innovation in Israel.

4.3 Market Restraints

4.3.1 High cost associated with metabolomics technologies and services limiting market adoption.

4.3.2 Lack of skilled professionals in metabolomics research and analysis.

4.3.3 Stringent regulatory requirements and ethical considerations in metabolomics research.

6.1 Israel Metabolomics Market, By Application

6.1.1 Overview and Analysis

6.1.2 Israel Metabolomics Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 Israel Metabolomics Market Revenues & Volume, By Biomarker Discovery, 2021- 2031F

6.1.4 Israel Metabolomics Market Revenues & Volume, By Drug Discovery, 2021- 2031F

6.1.5 Israel Metabolomics Market Revenues & Volume, By Toxicology Testing, 2021- 2031F

6.1.6 Israel Metabolomics Market Revenues & Volume, By Nutrigenomics, 2021- 2031F

6.1.7 Israel Metabolomics Market Revenues & Volume, By Personalized Medicine, 2021- 2031F

6.1.8 Israel Metabolomics Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Metabolomics Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Israel Metabolomics Market Revenues & Volume, By Oncological Disorders, 2021- 2031F

6.2.3 Israel Metabolomics Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F

6.2.4 Israel Metabolomics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.2.5 Israel Metabolomics Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F

6.2.6 Israel Metabolomics Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Metabolomics Market, By End-user

6.3.1 Overview and Analysis

6.3.2 Israel Metabolomics Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F

6.3.3 Israel Metabolomics Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F

6.3.4 Israel Metabolomics Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F

7.1 Israel Metabolomics Market Export to Major Countries

7.2 Israel Metabolomics Market Imports from Major Countries

8.1 Number of research grants and funding received for metabolomics projects in Israel.

8.2 Rate of adoption of metabolomics technologies in academic and research institutions.

8.3 Number of collaborations and partnerships between Israeli metabolomics companies and research organizations.

8.4 Growth in the number of metabolomics research publications originating from Israel.

8.5 Rate of development and commercialization of metabolomics-based diagnostic tools and therapies in Israel.

9.1 Israel Metabolomics Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 Israel Metabolomics Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 Israel Metabolomics Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 Israel Metabolomics Market Revenue Share, By Companies, 2024

10.2 Israel Metabolomics Market Competitive Benchmarking, By Operating and Technical Parameters